New tool helps pregnant women in malawi choose HIV prevention wisely
NCT ID NCT06394323
First seen Jan 07, 2026 · Last updated May 19, 2026 · Updated 22 times
Summary
This study tested a new way to help pregnant women in Malawi decide whether to take daily pills (PrEP) to prevent HIV. About 100 HIV-negative pregnant women were split into two groups: one received the new decision-making tool, and the other got standard advice. The goal was to see if the tool was easy to use and helpful for making personal choices about HIV prevention.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bwaila Hospital
Lilongwe, Central Region, Malawi
Conditions
Explore the condition pages connected to this study.